We are live on ! Find out more
VVA

Vida Ventures Advisors Portfolio holdings

AUM $29.4M
1-Year Est. Return 93.58%
This Fund
S&P 500
This Quarter Est. Return
-12.11%
1 Year Est. Return
+93.58%
3 Year Est. Return
+153.74%
5 Year Est. Return
+14.63%
10 Year Est. Return
–
AUM
$396M
AUM Growth
-$91.4M
Cap. Flow
+$12.5K
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
1
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
+$12.5K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRAX icon
1
Praxis Precision Medicines
PRAX
$8.8B
$96.3M 24.33%
195,955
– –
KNTE
2
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$85.6M 21.63%
2,747,433
+359
+0% +$12.5K
KRON
3
DELISTED
Kronos Bio
KRON
$80.9M 20.45%
2,765,314
– –
ALLO icon
4
Allogene Therapeutics
ALLO
$604M
$63.5M 16.04%
1,798,163
– –
DYN icon
5
Dyne Therapeutics
DYN
$4.24B
$46M 11.61%
2,960,046
– –
OYST
6
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$14.2M 3.59%
778,468
– –
QTTB icon
7
Q32 Bio
QTTB
$452M
$7.25M 1.83%
42,825
– –
ASMB icon
8
Assembly Biosciences
ASMB
$513M
$2.07M 0.52%
37,500
– –

Similar funds

NC
Nucleo Capital Sao Paulo, Sp, Brazil $29.1M AUM 59.16% 1-Year Est. Return
PIM
Pinnacle Investment Management Hong Kong $28.9M AUM 32% 1-Year Est. Return
NCPI
NewView Capital Partners I Burlingame, California $28M AUM 10.55% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
RE
ROB Exploration New York $27.3M AUM 13.99% 1-Year Est. Return
VM
Valinor Management New York $32.2M AUM 44.16% 1-Year Est. Return
BCA
Burren Capital Advisors Gibraltar $33M AUM 47.67% 1-Year Est. Return
VCM
Vector Capital Management San Francisco, California $24.4M AUM 14.95% 1-Year Est. Return

Vida Ventures Advisors's Q1 2021 Portfolio in Review

As of Q1 2021, Vida Ventures Advisors held 8 positions worth $396M, down 19% from $487M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2021: portfolio turnover was 0%. Vida Ventures Advisors opened no new positions and made no exits, leaving the 8-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Vida Ventures Advisors added most to Kinnate Biopharma Inc. Common Stock in Q1 2021, an estimated $12.5K increase.
  • Vida Ventures Advisors's ten largest holdings make up 100% of its $396M portfolio in Q1 2021.
  • Vida Ventures Advisors opened 0 new positions and closed 0 in Q1 2021.
  • Vida Ventures Advisors's portfolio value fell 19% quarter-over-quarter to $396M.

Based on Vida Ventures Advisors's 13F filing for Q1 2021, filed 11 May 2021.